Related Experiment Video

Updated: Jul 16, 2026

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo
09:19

Evaluating the Effectiveness of Cancer Drug Sensitization In Vitro and In Vivo

Published on: February 6, 2015

Compromised Fanconi anemia response due to BRCA1 deficiency in cisplatin-sensitive head and neck cancer cell lines

Kyunghee Burkitt1, Mats Ljungman

  • 1Department of Radiation Oncology, University of Michigan Medical School, University of Michigan, Ann Arbor, MI 48109-2200, USA.

Cancer Letters
|February 27, 2007
PubMed

Insights

Head and neck cancers treated with cisplatin show varied responses. This study links cisplatin resistance to the Fanconi anemia and BRCA pathway (FA/BRCA), particularly BRCA1 function, in head and neck cancer cells.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Research

Background:

  • Cisplatin is a key DNA-damaging agent for head and neck cancers.
  • Tumor response to cisplatin varies, and the underlying mechanisms are not fully understood.
  • The Fanconi anemia and BRCA pathway (FA/BRCA) is crucial for DNA repair and response to DNA cross-linking agents.

Purpose of the Study:

  • To investigate if the FA/BRCA pathway status predicts cisplatin sensitivity in head and neck cancer cells.
  • To elucidate the role of FA/BRCA pathway components, specifically BRCA1, in mediating cisplatin resistance.

Main Methods:

  • Assessed cisplatin sensitivity in head and neck cancer cell lines.
  • Evaluated the formation of FANCD2 nuclear foci following cisplatin treatment.
  • Investigated the role of BRCA1 by expressing exogenous BRCA1 in deficient cell lines.

Main Results:

  • Cisplatin-sensitive cell lines exhibited defective FANCD2 foci formation post-cisplatin treatment.
  • Cisplatin-resistant cell lines showed proficient FANCD2 foci formation.
  • Defective foci formation was linked to reduced BRCA1 expression or function, not FANCD2 monoubiquitylation.

Conclusions:

  • BRCA1 status and FA/BRCA pathway functionality correlate with cisplatin sensitivity in head and neck cancers.
  • Restoring BRCA1 function can enhance cisplatin sensitivity and resistance.
  • BRCA1 may be a key modulator of treatment response in these cancers.

More Related Videos

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity04:20

Knockdown of FAM83A to Verify Its Role in Cervical Cancer Cell Growth and Cisplatin Sensitivity

Published on: February 9, 2024

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA108:53

Identifying the Effects of BRCA1 Mutations on Homologous Recombination using Cells that Express Endogenous Wild-type BRCA1

Published on: February 17, 2011

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
DNA Damage Can Stall the Cell Cycle02:36

DNA Damage Can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...